| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0067 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |